Features July 2007 Issue

Options Sought After Drug Study

Patients who take rosiglitazone might consider pioglitazone instead.

Diabetes patients concerned about taking rosiglitazone (Avandia) after a recent study linked the drug to a higher risk of heart attacks may have a safer option, the study’s author says. Pioglitazone (Actos) is from the same class of thiazolidenediones as rosiglitazone. Thiazolidenediones make insulin work more effectively and lower blood sugar levels in patients with Type 2 diabetes.

To continue reading this article you must be a paid subscriber.

Subscribe to Heart Advisor

Get the next year of HEART ADVISOR for just $20. That's a savings of $19 off the regular rate.

With your paid subscription you will receive unlimited access to all of our online content. That is over a decade of previous issues from Cleveland Clinic, the hospital rated #1 in cardiac care by U.S. News & World Report - free of charge.

Subscriber Log In

Forgot your password? Click Here.

Already subscribe but haven't registered for all the benefits of the website? Click here.